Effect of Amalakibhavita Nisha on Madhumeha (Type 2 Diabetes)

Etiopathological study of Madhumeha (Type 2 Diabetes) and itâ??s management by Amalakibhavita Nisha

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/05/008592

Enrollment

Registered

2017-05-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Madhumeha (Type 2 Diabetes)

Interventions

Intervention1: Amalaki bhavit Nisha: 2 tablets (500mg each) twice a day with luke warm water after meal for 8 Weeks Intervention2: Amalakibhavita Nisha: dose 2 tablets (500 mg each) BD with water aft

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed/known case of Madhumeha (Type 2 Diabetes) with FBS more than 126 mg/dl and less than 300 mg/dl PPBS greater than 140 mg/dl and less than 300 mg/dl With or without symptoms of Madhumeha (Type 2 Diabetes)

Exclusion criteria

Exclusion criteria: Age less than 30 years more than 60 years. FBS or PP2BS greater tha 300 mg per dl (any). Patients receiving insulin, secondary DM, gestational DM, pregnant women lactating mother

Design outcomes

Primary

Measure	Time frame
efficacyTimepoint: 2 month	—

Secondary

Measure	Time frame
safetyTimepoint: 2 month	—

Countries

India

Contacts

Public ContactDr Vasundhara sharma

IPGT and RA Gujarat Ayurved University Jamnagar Gujarat 361008

drkspatel2007@yahoo.co.in9427574566

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026